Provided by Tiger Trade Technology Pte. Ltd.

Eton Pharmaceuticals, Inc.

63.47
+3.565.94%
Post-market: 63.940.4700+0.74%19:44 EDT
Volume:640.79K
Turnover:40.08M
Market Cap:1.81B
PE:162.74
High:64.00
Open:59.76
Low:59.76
Close:59.91
52wk High:64.00
52wk Low:14.27
Shares:28.58M
Float Shares:26.68M
Volume Ratio:0.56
T/O Rate:2.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3900
EPS(LYR):-0.1710
ROE:35.97%
ROA:11.86%
PB:38.94
PE(LYR):-371.19

Loading ...

Eton Pharma President and CEO Sean Brynjelsen Sells USD 6.19 Million in Common Shares

Reuters
·
Aug 21

Dow Falls Over 100 Points, Records Weekly Loss: Investor Sentiment Weakens, but Fear Index Remains in ‘Greed’ Zone

Benzinga Earnings
·
Aug 17

Eton Pharmaceuticals price target raised to $70 from $40 at B. Riley

TIPRANKS
·
Aug 16

Emmaus Life Sciences Q2 Revenue Soars on Licensing Deal

Reuters
·
Aug 15

Eton Pharmaceuticals is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Aug 15

Top Midday Gainers

MT Newswires Live
·
Aug 15

Scienture Q2 Revenue Surges on Rezenopy Launch

Reuters
·
Aug 14

B. Riley Adjusts Price Target on Eton Pharmaceuticals to $70 From $40, Maintains Buy Rating

MT Newswires Live
·
Aug 14

U.S. Stocks on the MOVE-Reddit, Capricor Therapeutics, Birkenstock

Reuters
·
Aug 14

Eton Pharmaceuticals Shares Rise 24.3% Premarket After Q2 Profit Beat

THOMSON REUTERS
·
Aug 14

Eton Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $70 from $65

THOMSON REUTERS
·
Aug 14

Eton Pharmaceuticals Shares Rise in Extended Trade Following Results, Last up 18.2% at $48.25

THOMSON REUTERS
·
Aug 14

Eton Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Eton Pharmaceuticals Q2 Adjusted Earnings, Revenue Rise

MT Newswires Live
·
Aug 14

Eton Pharmaceuticals Q2 Adj. EPS $0.43 Beats $0.10 Estimate, Sales $37.568M Beat $27.119M Estimate

Benzinga Earnings
·
Aug 14

GUIDANCE: (ETON) Eton Pharmaceuticals Expects Full Year 2026 Revenue Over $145M, vs. FactSet Est of $121.3M

MT Newswires Live
·
Aug 14

Eton Pharmaceuticals Q2 Net Income USD 11.578 Million

Reuters
·
Aug 14

Eton Pharmaceuticals Inc: ‍Company NOW Expects 2026 Revenues to Exceed $145 Mln​

THOMSON REUTERS
·
Aug 14

Eton Pharmaceuticals Inc: ‍ Company NOW Expects to Report at Least a 35% Adjusted Ebitda Margin in 2026​

THOMSON REUTERS
·
Aug 14

Eton Pharmaceuticals Q2 EPS USD 0.35

THOMSON REUTERS
·
Aug 14